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Trends in the Prevalence of Ketoacidosis at Diabetes
Diagnosis: The SEARCH for Diabetes in Youth Study
WHAT’S KNOWN ON THIS SUBJECT: Diabetic ketoacidosis (DKA) is
a life-threatening condition and often the presenting symptom of
newly diagnosed type 1 or type 2 diabetes in youth. SEARCH
previously reported that the prevalence of DKA at diagnosis was
25.5% in 2002–2003.
WHAT THIS STUDY ADDS: DKA in youth with type 1 diabetes
remains a problem, with almost one-third presenting with DKA.
Among youth with type 2 diabetes, DKA was less common and
decreased by ∼10% per year, suggesting improved detection or
earlier diagnosis.
abstract
OBJECTIVE: To estimate temporal changes in the prevalence of diabetic
ketoacidosis (DKA) at diagnosis of type 1 or type 2 diabetes in youth
and to explore factors associated with its occurrence.
METHODS: Five centers identified incident cases of diabetes among
youth aged 0 to 19 years starting in 2002. DKA presence was defined
as a bicarbonate level ,15 mmol/L and/or a pH ,7.25 (venous) or
,7.30 (arterial or capillary) or mention of DKA in the medical
records. We assessed trends in the prevalence of DKA over 3 time
periods (2002–2003, 2004–2005, and 2008–2010). Logistic regression
was used to determine factors associated with DKA.
RESULTS: In youth with type 1 diabetes (n = 5615), the prevalence of
DKA was high and stable over time (30.2% in 2002–2003, 29.1% in
2004–2005, and 31.1% in 2008–2010; P for trend = .42). Higher prev-
alence was associated with younger age at diagnosis (P , .0001),
minority race/ethnicity (P = .019), income (P = .019), and lack of private
health insurance (P = 008). Among youth with type 2 diabetes (n =
1425), DKA prevalence decreased from 11.7% in 2002–2003 to 5.7% in
2008–2010 (P for trend = .005). Higher prevalence was associated with
younger age at diagnosis (P = .001), minority race/ethnicity (P = .013),
and male gender (P = .001).
CONCLUSIONS: The frequency of DKA in youth with type 1 diabetes,
although stable, remains high, indicating a persistent need for in-
creased awareness of signs and symptoms of diabetes and better ac-
cess to health care. In youth with type 2 diabetes, DKA at onset is less
common and is decreasing over time. Pediatrics 2014;133:e938–e945
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The SEARCH for Diabetes in Youth Study
has estimated that there were at least
188 811 youth with diabetes in the
United States in 2009: 168 141 with type
1 diabetes and 19 147 with type 2 di-
abetes.1 In the United States2 and
worldwide,3 the incidence of type 1 di-
abetes in youth has been increasing by
3% to 4% per year, with limited esti-
mates for type 2 diabetes except in
minority populations in whom in-
creased prevalence has also been
reported.4 Diabetic ketoacidosis (DKA)
due to insulin deficiency can be a life-
threatening condition, and is often the
presenting symptom of new-onset
cases in both type 1 and type 2 di-
abetes.5 It has been reported to be
present in 25% to 30% of type 1
diabetes cases at onset6–10 and from
4% to 29% in youth with type 2 diabetes,
depending on race/ethnicity.10–14 SEARCH
previously reported that the prevalence
of DKA at diagnosis was 25.5% in 2002–
2003.10
It is not known whether the presence
of DKA at diagnosis has changed over
time. It has been decreasing in Sweden15
and Finland16,17 from the late 1970s to
themid-2000s, coincident with programs
aimed at increasing DKA awareness.
However, no such trends were reported
from Austria or Germany.18–20 There is
limited long-term trend information in
youth with type 1 diabetes from North
American populations,21–23 and to our
knowledge, no trend data on DKA among
youth with type 2 diabetes. Thus, the goal
of this analysiswas to estimate temporal
changes in the prevalence of DKA at di-
abetes onset among youth aged 0 to 19
years when diagnosed with type 1 or
type 2 diabetes, overall and by age,
gender, and race/ethnicity, and to ex-
plore factors associated with its occur-
rence over time.
METHODS
Data for this analysis derive from the
registry component of the SEARCH for
Diabetes in Youth Study. The study pro-
tocol was reviewed and approved by
the local institutional review boards
that had jurisdiction. All centers com-
plied with the privacy requirements of
the Health Insurance Portability and
Accountability Act. Because the SEARCH
registry attempts to identify 100% of
all cases, case identification was con-
ducted with an approved Health In-
surance Portability and Accountability
Act consent waiver at most locations.
Written informed consent/assent for
a study visit was obtained according
to the local institutional review board
requirements.
A detailed description of the SEARCH
methods has been published.24,25 In
brief, SEARCH is an ongoing multi-
center study that, in 2002, began
population-based ascertainment of in-
cident cases of diabetes in youth aged
0 to 19 years of age. Cases are identi-
fied as follows: (1) in geographically
defined populations in the states of
Ohio, Washington, South Carolina, and
Colorado; (2) among health plan
enrollees in Kaiser Permanente Southern
California; and (3) coordinated by the
Colorado site, among Indian Health
Service beneficiaries in American
Indian populations in Arizona and New
Mexico. Active surveillance systems
were based on networks of pediatric
and adult endocrinologists, existing
pediatric diabetes databases, hospitals,
clinical databases and electronic health
records, and other health care pro-
viders. All case reports were validated
on the basis of physician reports or
medical record review and only vali-
dated and eligible cases were included.
Case reports were registered anony-
mously with the coordinating center at
Wake Forest School of Medicine (Winston-
Salem, NC).
Persons with diabetes $18 years of
age identified by the SEARCH recruiting
network and parents of youth ,18
years were asked to complete an initial
survey that included their age at di-
agnosis, treatment history, race or
ethnicity, insurance, and parental edu-
cation. Medical records for the period
from diagnosis to 6 months after di-
agnosis were reviewed to collect in-
formation on the prevalence of DKA at
diagnosis. This protocol was con-
ducted for all registered cases under
a waiver of written informed consent
from most participating institutions.
This report covers 3 intervals span-
ning a 9-year time period from 2002
to 2010 (2002–2003, 2004–2005, and
2008–2010), because information to
assess the presence of DKA was not
collected for the cohorts diagnosed in
2006 and 2007. Methods used over
time were identical in each interval.
The availability of medical record data
to assess DKA was somewhat higher
for youth with type 1 diabetes (on av-
erage, 22% missing records, improv-
ing over time from 26% to 19%) than
for youth with type 2 diabetes (on av-
erage, 26% missing records, improv-
ing over time from 39% to 14%). This
situation was due to variation in in-
stitutional review board practices at
participating institutions and hospi-
tals, both within and across sites, in
granting permission to review medi-
cal records under a waiver of written
informed consent. All trend analyses
included only youth with available
medical record data. Because in-
formation about insurance, income,
and parental education was in-
consistently available in the medical
records, the associations between
these factors and DKA at diagnosis
were examined only in the subset
of participants for whom both medi-
cal records and survey data were
available.
Definitions of Variables
DKA was considered to be present if,
in the context of hyperglycemia, any of
the following were present: a blood
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bicarbonate level,15 mmol/L, and/or
a pH , 7.25 (venous) or ,7.30 (arte-
rial or capillary), and/or a DKA di-
agnosis mentioned in the medical
records.10
Data on race and ethnicity were based
on self-reports or medical records. On
the basis of 2000 US Census classifi-
cation, participants were categorized
as Hispanic, African-American, Asian
or Pacific Islander, American Indian,
non-Hispanicwhite, andmultiple, other,
or unknown race. Classification of di-
abetes type was determined on the
basis of the clinical diagnosis made by
a health care provider and was col-
lected from the providers at the time of
thecasereport toSEARCHorabstracted
from medical records. The clinical type
was categorized as type 1 (including 1A,
1B), type 2, or other or unknown di-
abetes type. Clinical diabetes type was
previously shown to be consistent with
an etiologic classification of diabetes
type on the basis of autoimmunity and
insulin resistance, as assessed by the
SEARCH study.26 Family income, highest
parental education, and type of health
insurance were obtained through the
health questionnaire or initial partici-
pant survey. Responses to questions
about health insurance sources, which
allowed multiple choices, were cate-
gorized hierarchically as “private,”
which included private only and private
plus anything else, and “other/none,”
which included Medicaid only, Indian
Health Service only, other types of in-
surance, and none. Parental educa-
tional attainment is that of the parent
with the higher attainment.
Overall, therewere 9213 youth aged 0 to
19 years diagnosedwith type 1 or type 2
diabetes and registered in 2002–2003,
2004–2005, and 2008–2010. We ex-
cluded 2099 (23%) incident cases due
to missing medical records and an-
other 74 cases of type 2 diabetes aged
,10 years, leaving 7040 youth for this
analysis (5615 with type 1 diabetes
aged 0–19 years and 1425 with type 2
diabetes aged 10–19 years).
Statistical Analysis
Statistical analyses were performed by
using SAS 9.3 (SAS Institute, Cary, NC).
The period prevalence of DKA at di-
agnosis (per 100 youth with type 1 or
type 2 diabetes) was calculated, along
with 95% confidence intervals (CIs), by
age group, gender, and race/ethnicity.
Poisson regression was used to test
for change over time within each
stratum of interest. Multivariable lo-
gistic regression analyses were used
to identify factors associated with DKA
at diagnosis over time. In thesemodels,
time was treated as a continuous/
ordinal variable to examine whether
there was a linear trend, and specifi-
cally to take into account the unequal
spacing between time categories. All
of the tests were 2-sided, and a P
value,.05 was considered statistically
significant.
RESULTS
There were 7040 youth with new-onset
diabetes available for this analysis:
5615 had type 1 and 1425 had type 2
diabetes. Table 1 shows the prevalence
of DKA by type of diabetes, time period,
and age group.
Type 1 Diabetes
Among youth with type 1 diabetes, the
prevalence did not significantly change
over time, with a prevalence of 30.2%
(95% CI: 27.8%–32.5%) in 2002–2003,
29.1% (95% CI: 26.9%–31.4%) in 2004–
2005, and 31.1% (95% CI: 29.3%–32.9%)
in 2008–2010 (P for trend = .42). The
overall prevalence was highest in the
0- to 4-year age group (∼39%) and
lowest in the 15- to 19-year age group
(∼23%) . No changes over time in DKA
at onset were observed within each
age group.
Figure 1 A and B shows the changes
over time in the prevalence of DKA at
diagnosis in youth with type 1 diabetes
by gender and race/ethnicity, re-
spectively. Rates were similar in boys
and girls but higher in Hispanic and
African-American youth than among
non-Hispanic white youth. Due to small
numbers we were unable to explore
trends in Asian Pacific Islander or
American Indian youth. However, there
were no statistically significant gender-
or race/ethnicity-specific changes over
time.
We used logistic regression to explore
whether our findings were influenced
by adjustment for sociodemographic
factors and to determine whether such
factors were associated with DKA at
diagnosis. Table 2 shows that, after
adjustment, there were no significant
changes over time in DKA at onset of
type 1 diabetes. However, across the
entire time period, younger youth had
a significantly higher prevalence of
DKA than those diagnosed at older ages.
Similarly, nonwhite youth had a higher
prevalence than did non-Hispanic whites,
as did those without private insurance
(by 22% and 31%, respectively). House-
hold income showed a significant asso-
ciation with DKA, where households in
the $25 000 to $49 000 range had signif-
icantly higher odds of DKA than did those
in the $50 000 to $74 000 range. Gender
and parental education were not signif-
icantly independently associated with
DKA among youth with type 1 diabetes.
Type 2 Diabetes
Table 1 also shows the trends for youth
with type 2 diabetes aged 10 to 19
years, because there were too few un-
der the age of 10 to estimate rates of
DKA in each period. The prevalence
decreased from 11.7% (95% CI: 8.2%–
15.2%) in 2002–2003 to 6.3% (95% CI:
3.7%–8.9%) in 2004–2005 and 5.7%
(95% CI: 4.1%–7.4%) in 2008–2010
(P for trend = .005). DKA at onset was
e940 DABELEA et al
more common among youth aged 10 to
14 years than in 15- to19-year-old
youth, and changes over time were
somewhat more pronounced in the
younger group (P for trend = .02 vs .08
in the older group). There were too few
cases with type 2 diabetes to stratify
by gender or race/ethnic group. In
multivariate logistic regression
analyses, among youth with type 2 di-
abetes, there was an ∼10% per year
decrease in DKA prevalence after ad-
justment for sociodemographic fac-
tors (odds ratio = 0.90, P = .004).
Younger onset age, minority race/
ethnicity, and male gender had signifi-
cantly higher DKA prevalence. Due to
very small numbers and missing data,
we were not able to explore the role of
parental education, health insurance, or
household income in youth with type 2
diabetes.
In addition to fitting a model that
treated year as an ordinal variable, we
also examined year as a categorical
variable. We found similar results for
type 1 and 2 diabetes patients as seen
with the ordinal variable parameteri-
zation; however, there was some evi-
dence that the change in prevalence
of DKA over time for type 2 diabetes
participants was stronger in the early
years (2002–2003 and 2004–2005) than
in the later years (2004–2005 vs 2008–
2010).
DISCUSSION
We have shown that the prevalence of
DKA at diagnosis of diabetes, a life-
threatening but potentially prevent-
able condition, remains an important
problem. The frequency of DKA in youth
with type 1 diabetes appears to be
stable but remains high, with almost
one-third of all youth with type 1 di-
abetes presentingwith DKA, suggesting
a persistent need for increased
awareness of signs and symptoms of
diabetes and better access to health
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2 diabetes, DKA was less common and
decreased by ∼10% per year, sug-
gesting improved detection of
symptoms or diagnosis earlier in the
clinical course.
Type 1 Diabetes
The rates of DKA among youth with type
1 diabetes were similar to the 29%
prevalence reported in Colorado for
the period 1998–200121 and the 28%
prevalence from a single center in
Denver, Colorado,27 in 2002–2003.10
A previous report from the Colorado
IDDM (insulin-dependent diabetes
mellitus) Registry reported a higher
prevalence of 38% in 1978–1982, sug-
gesting that a longer period of ob-
servation may identify decreasing DKA
trends among youth with type 1 di-
abetes.
The DKA prevalence among type 1 youth
with onset at ,15 years was 33% in
the 24 centers in the Eurodiab Study
in 1989–1994.28 In Sweden, the preva-
lence ranged from 9% to 14% across
ages 0 to 5 to 11 to 15 years at onset in
1997–2001.15 DKA prevalence in northern
Finland was also somewhat lower than
we report, at 18.9% in 1992–2001.17 In
both of these areas, declines in DKA
were seen from earlier periods. How-
ever, in Germany, among.14 000 youth
from 106 centers, the prevalence was
21.1%,20 with no decrease over time,
which was consistent with our findings.
A lack of decline in DKA at presentation
was also reported from Austria (1989–
2008), although the prevalence of DKA
was higher than in SEARCH (37.2% at
onset).19
Similar to our data, a systematic review
of 46 studies involving .24 000 chil-
dren in 31 countries worldwide identi-
fied younger age, ethnic minority, and
lack of health insurance, among oth-
ers, as major risk factors for DKA at
onset with type 1 diabetes.29 Younger
age was consistently associated with
increased risk of DKA at onset in nu-
merous studies, and the reasons are
likely multifactorial.29 Toddlers are less
likely to verbalize symptoms and early
symptom recognition is more difficult
in young children, leading to delayed
diagnosis and treatment. On the other
hand, young children may experience
more aggressive and faster metabolic
deterioration.15 The Environmental De-
terminants of Diabetes in the Young
(TEDDY) Study recently found that DKA
prevalence in youth ,5 years of age
who were followed regularly and edu-
cated about diabetes in the TEDDY study
was lower than among registry youth
who were not under follow-up, sug-
gesting that parental education, closer
monitoring of signs and symptoms of
diabetes, and knowledge of being at
high risk of type 1 diabetes can result
in lower DKA prevalence at onset of di-
abetes.30 Finally, our findings of a higher
prevalence of DKA in minority youth
with type 1 diabetes, youth without
FIGURE 1
A, Prevalence of DKA at diagnosis of type 1 diabetes by gender. B, Prevalence of DKA at diagnosis of
type 1 diabetes by race/ethnicity and year. AA, African-American; HISP, Hispanic; NHW, non-Hispanic
white.
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private insurance, and those with low-
er family income are consistent with
previous US reports31 and suggest a
persistent need for improved health
care access.
Type 2 Diabetes
Among youth with type 2 diabetes, in-
formation on the occurrence of DKA at
onset is limited, and our study is the
first, to our knowledge, to report on
potential changes over time. Estimates
of DKA prevalence at onset with type
2 diabetes vary substantially, from
41.4%and 16%among African-American
youth in Cincinnati14 and Arkansas,
respectively,13 to 8% among African
Canadians and Southeast Asians in
Toronto,11 and 4.2% among Canadian
Aboriginal youth.12 We found that a
higher prevalence of DKA was associ-
ated with younger age, minority race/
ethnicity, and male gender. Whereas
we do not have a direct explanation
for the observed decreasing trend
over time, possible explanations in-
clude improved access to care (al-
though adjustment for minority racial/
ethnic group did not account for
changes in DKA prevalence) and/or im-
proved diagnosis in at-risk individuals
(although we were not able to docu-
ment significant differences in hemo-
globin A1c levels over time among
youth who had a baseline study visit:
mean (SD) levels in the 3 periods were
7.54% (2.31%), 7.18% (2.03%), and
7.55% (2.06%), respectively. In addi-
tion, future years of data may be
useful to examine whether the ob-
served changes in DKA prevalence in
youth with type 2 diabetes are leveling
off or not.
Limitations and Strengths
Our study has some limitations. The
period of assessment was only 9 years,
which may have limited our ability
to detect small changes in DKA preva-
lence in specific racial/ethnic groups.
The availability of medical records to
assess the presence of DKA was not
complete, and cases with missing
records were excluded. However, in
youth with type 1 diabetes, we found
no major differences between de-
mographic characteristics of youth with
and without medical record data
available. In contrast, in youth with type
2 diabetes, the proportion withmissing
records declined substantially over
time, and minority youth were more
likely than non-Hispanic white youth to
have missing medical record data in
each time period. Because minority
youth had a higher DKA prevalence,
this finding may have underestimated
the observed decrease in DKA preva-
lence over time in youth with type 2
diabetes. We used a provider as-
sessment of diabetes type for these
analyses, which is especially prob-
lematic in youth with type 2 diabetes.
However, we have previously shown
good agreement between provider
assessment of diabetes type and eti-
ologic diabetes type.26 Also, our find-
ing of a decreasing prevalence of
DKA in youth with type 2 diabetes over
time was maintained after excluding
a small number of participants with
type 2 diabetes and positive auto-
antibodies. Strengths of the study
include the population-based design
with consistent definitions of DKA
over time, the largest and most di-
verse US sample of youth with type 1
diabetes, and the first report of
changes over time in DKA in type 2
diabetes in youth.
CONCLUSIONS
We found no evidence that DKA at
diabetes onset among youth with
type 1 diabetes has been changing
over time in centers located in mul-
tiple geographic areas in the United
States. Across the study period, a
higher DKA prevalence was inde-
pendently associated with younger
onset age, minority race/ethnicity,
lower family income, and lack of
private insurance. Although stable,
the prevalence of DKA remains high
among US children at diagnosis with
type 1 diabetes, indicating a continu-
ing need for increased awareness of
the signs and symptoms of type 1
diabetes and better access to health
care. In youth with type 2 diabetes,
DKA at onset is less common and
seems to be decreasing over time,
TABLE 2 Correlates of DKA by Type of Diabetes: The SEARCH for Diabetes in Youth Study (2002–
2003, 2004–2005, and 2008–2010) Incident Cases
Odds Ratio 95% CI
Type 1 diabetes (n = 3706)
Time (per 1 year) 1.013 0.988–1.039
Onset age
5–9 vs 0–4 years 0.577 0.474–0.704
10–14 vs 0–4 years 0.729 0.602–0.882
15–19 vs 0–4 years 0.389 0.293–0.518
Race: Nonwhite versus NHW 1.218 1.033–1.436
Insurance: other/none versus private 1.312 1.075–1.602
Income
,$25 000 vs $50 000–$75 000 1.162 0.872–1.548
$25 000–49 vs $50 000–$75 000 1.339 1.066–1.683
$$75 000 vs $50 000–$75 000 0.951 0.771–1.173
Refused versus $50 000–$75 000 1.115 0.822–1.513
Type 2 diabetes (n = 1388)
Time (per 1 year) 0.904 0.843–0.969
Onset age: 15–19 vs 10–14 years 0.500 0.327–0.765
Race: Non-white versus NHW 2.204 1.183–4.105
Gender: female versus male 0.505 0.334–0.762
Cases with missing medical record data were excluded from these analyses. NHW, non-Hispanic white.
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suggesting improved diagnosis in at-
risk individuals. With changes in the
availability of health insurance and
associated health care access on the
horizon, it may be possible to begin
reducing DKA rates in the near future,
although it is likely that additional
outreach to minority populations
will be needed to decrease DKA in
these groups.
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